社區中老年2型糖尿病居家日常護理個人化指引生成

首頁

AI 提示詞列表

醫療健康

社區糖尿病居家護理指引生成

${:__('collect %s',社區糖尿病居家護理指引生成)}$

醫療健康

為社區確診的中老年2型糖尿病患者，結合他們的日常作息、飲食偏好與合併基礎病情況，生成可落實的居家日常護理個人化指引

提示內容

複製

Based on the daily routine, diet preference, comorbidities and current blood glucose control level provided by elderly community-dwelling type 2 diabetes patients, create a personalized home daily care guide that fits ordinary family operation conditions and is easy for middle-aged and elderly people to remember and follow. The guide covers daily diet matching, activity intensity suggestions, blood glucose monitoring frequency and abnormal response methods, with plain language that avoids complex jargon and adapts to home scenario implementation.

複製

結合社區中老年2型糖尿病患者提供的日常作息習慣、飲食偏好、合併的其他基礎疾病情況和當前血糖控制水準，整理生成符合普通家庭操作條件、適合中老年記憶執行的個人化居家日常護理指引，內容涵蓋日常飲食搭配、活動強度建議、血糖監測頻率與異常應對方法，內容要淺顯易懂，避免複雜專業術語，適配居家場景執行。

複製

分享點擊複製鏈接

評論 (0)

0/300

提交

推薦

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.

處方審核助手

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.

處方審核助手

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.

處方審核助手

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.

處方審核助手

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's hepatic and renal function status. Identify any risk points based on the latest clinical guidelines, and finally provide adjustment suggestions or confirm safety, ensuring the output is concise and clinically actionable.